NCT00331916View on ClinicalTrials.gov

AL-15469A for the Treatment of Bacterial Conjunctivitis

PHASE3CompletedINTERVENTIONAL

Enrollment

600

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

May 31, 2007

Conditions

Bacterial Conjunctivitis

Interventions

DRUG

quinolone

Trial Locations (1)

76134

US, Fort Worth

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alcon Research

INDUSTRY